JP2018527354A5 - - Google Patents

Download PDF

Info

Publication number
JP2018527354A5
JP2018527354A5 JP2018511436A JP2018511436A JP2018527354A5 JP 2018527354 A5 JP2018527354 A5 JP 2018527354A5 JP 2018511436 A JP2018511436 A JP 2018511436A JP 2018511436 A JP2018511436 A JP 2018511436A JP 2018527354 A5 JP2018527354 A5 JP 2018527354A5
Authority
JP
Japan
Prior art keywords
optionally substituted
pharmaceutically acceptable
acceptable salt
alkyl
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018511436A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018527354A (ja
JP6898310B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/049526 external-priority patent/WO2017040545A1/en
Publication of JP2018527354A publication Critical patent/JP2018527354A/ja
Publication of JP2018527354A5 publication Critical patent/JP2018527354A5/ja
Priority to JP2021096263A priority Critical patent/JP7463318B2/ja
Application granted granted Critical
Publication of JP6898310B2 publication Critical patent/JP6898310B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018511436A 2015-09-02 2016-08-30 ６員アザヘテロ環を含有するデルタ−オピオイド受容体調節化合物、同化合物を使用する方法、および同化合物を作る方法 Active JP6898310B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021096263A JP7463318B2 (ja) 2015-09-02 2021-06-09 ６員アザヘテロ環を含有するデルタ－オピオイド受容体調節化合物、同化合物を使用する方法、および同化合物を作る方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562213203P 2015-09-02 2015-09-02
US62/213,203 2015-09-02
PCT/US2016/049526 WO2017040545A1 (en) 2015-09-02 2016-08-30 6-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021096263A Division JP7463318B2 (ja) 2015-09-02 2021-06-09 ６員アザヘテロ環を含有するデルタ－オピオイド受容体調節化合物、同化合物を使用する方法、および同化合物を作る方法

Publications (3)

Publication Number Publication Date
JP2018527354A JP2018527354A (ja) 2018-09-20
JP2018527354A5 true JP2018527354A5 (https=) 2019-10-10
JP6898310B2 JP6898310B2 (ja) 2021-07-07

Family

ID=58188367

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018511436A Active JP6898310B2 (ja) 2015-09-02 2016-08-30 ６員アザヘテロ環を含有するデルタ−オピオイド受容体調節化合物、同化合物を使用する方法、および同化合物を作る方法
JP2021096263A Active JP7463318B2 (ja) 2015-09-02 2021-06-09 ６員アザヘテロ環を含有するデルタ－オピオイド受容体調節化合物、同化合物を使用する方法、および同化合物を作る方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021096263A Active JP7463318B2 (ja) 2015-09-02 2021-06-09 ６員アザヘテロ環を含有するデルタ－オピオイド受容体調節化合物、同化合物を使用する方法、および同化合物を作る方法

Country Status (22)

Country Link
US (3) US10246436B2 (https=)
EP (2) EP3344248B1 (https=)
JP (2) JP6898310B2 (https=)
KR (1) KR102787317B1 (https=)
CN (2) CN114773318A (https=)
AU (2) AU2016315720B2 (https=)
CA (1) CA3015702A1 (https=)
CY (1) CY1125225T1 (https=)
DK (1) DK3344248T3 (https=)
ES (1) ES2920130T3 (https=)
HR (1) HRP20220735T1 (https=)
HU (1) HUE058819T2 (https=)
IL (1) IL257503B (https=)
LT (1) LT3344248T (https=)
MA (1) MA43313B1 (https=)
MD (1) MD3344248T2 (https=)
PL (1) PL3344248T3 (https=)
PT (1) PT3344248T (https=)
RS (1) RS63319B1 (https=)
SI (1) SI3344248T1 (https=)
SM (1) SMT202200377T1 (https=)
WO (1) WO2017040545A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11225487B2 (en) 2017-02-17 2022-01-18 Trevena, Inc. 7-membered aza-heterocyclic containing δ-opioid receptor modulating compounds, methods of using and making the same
BR112019016827A2 (pt) 2017-02-17 2020-04-07 Trevena Inc compostos moduladores de receptor delta-opioide contendo aza-heterocíclico com 5 membros, métodos de uso e produção dos mesmos
CN111533682B (zh) * 2020-05-29 2022-03-01 清华大学 帕罗西汀及其类似物的制备方法
CN113880815B (zh) * 2020-07-03 2024-03-29 中国药科大学 一类吲哚衍生物及其制备方法和用途
JP2023546729A (ja) * 2020-10-27 2023-11-07 トレベナ・インコーポレイテッド デルタオピオイドモジュレーターの結晶形及び非晶形
JP2022135015A (ja) * 2021-03-04 2022-09-15 国立大学法人東京工業大学 オピオイド受容体作動剤
WO2023070605A1 (en) * 2021-10-29 2023-05-04 Trevena, Inc. Methods of preparing 6-membered aza-heterocyclic containing delta-opioid receptor modulating compounds

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE352811B (https=) 1971-06-04 1973-01-15 Pharmacia Ab
US3960150A (en) 1971-09-09 1976-06-01 Alza Corporation Bioerodible ocular device
US3867519A (en) 1972-04-27 1975-02-18 Alza Corp Bioerodible drug delivery device
SE375007B (https=) 1972-11-30 1975-04-07 Pharmacia Ab
US3963025A (en) 1974-09-16 1976-06-15 Alza Corporation Ocular drug delivery device
JPS5825980B2 (ja) 1976-02-12 1983-05-31 ヤマサ醤油株式会社 サイクリックヌクレオチドの定量法
US4186184A (en) 1977-12-27 1980-01-29 Alza Corporation Selective administration of drug with ocular therapeutic system
US4303637A (en) 1980-04-04 1981-12-01 Alza Corporation Medication indicated for ocular hypertension
DK231088D0 (da) * 1988-04-28 1988-04-28 Ferrosan As Piperidinforbindelser, deres fremstilling og anvendelse
US5086063A (en) 1988-03-28 1992-02-04 Du Pont Merck Pharmaceutical Company 4-aryl-4-piperidine (or pyrrolidine or hexahydroazepine) carbinols and heterocyclic analogs thereof
US5401629A (en) 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
US5443505A (en) 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
US5869079A (en) 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
NZ325914A (en) * 1996-03-29 1999-09-29 Pfizer Benzyl(idene)-lactam derivatives and salts thereof, their preparation and their use as selective (ant)agonists of 5-ht1a and/or 5-ht1d receptors and thus are effective as psychotherapeutic agents
EP0912513A1 (en) 1996-06-28 1999-05-06 Merck & Co., Inc. Fibrinogen receptor antagonist prodrugs
EP1512683B1 (en) * 1998-03-10 2011-08-31 Research Triangle Institute Novel opiate compounds, methods of making and methods of use
WO2001032178A1 (en) 1999-10-29 2001-05-10 Novo Nordisk A/S Use of 3,4-substituted piperidines
WO2002000651A2 (en) 2000-06-27 2002-01-03 Bristol-Myers Squibb Pharma Company Factor xa inhibitors
US6995144B2 (en) 2002-03-14 2006-02-07 Eisai Co., Ltd. Nitrogen containing heterocyclic compounds and medicines containing the same
CN100372850C (zh) * 2003-02-12 2008-03-05 神经研究公司 新的8-氮杂-双环[3.2.1]辛烷衍生物和它们作为单胺神经递质再摄取抑制剂的用途
SE0301445D0 (sv) * 2003-05-16 2003-05-16 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
US7468437B2 (en) 2003-09-30 2008-12-23 Merck & Co., Inc. Phenyl pyrrolidine ether tachykinin receptor antagonists
US7488745B2 (en) 2004-07-16 2009-02-10 Schering Corporation Compounds for the treatment of inflammatory disorders
ATE478864T1 (de) 2004-07-16 2010-09-15 Schering Corp Hydantoinderivate zur behandlung von entzündlichen erkrankungen
US7504424B2 (en) 2004-07-16 2009-03-17 Schering Corporation Compounds for the treatment of inflammatory disorders
US7098203B2 (en) 2004-07-20 2006-08-29 Bristol-Myers Squibb Company Homopiperidine derivatives as NK-1 antagonists
US7872023B2 (en) 2005-02-17 2011-01-18 Research Triangle Institute Kappa opioid receptor ligands
TW200804307A (en) 2005-10-27 2008-01-16 Synta Pharmaceuticals Corp Process for preparing mesylate salts of IL-12 inhibitory compounds
EP1957450B1 (en) 2005-12-01 2009-06-24 F.Hoffmann-La Roche Ag Serotonin transporter (sert) inhibitors
US20070142389A1 (en) 2005-12-20 2007-06-21 Pfizer Inc. Piperidine derivatives
CA2646430A1 (en) 2006-03-14 2007-09-20 Amgen Inc. Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
DK2101740T3 (da) 2006-12-04 2013-11-18 Orexo Ab Nye ikke-misbrugs-farmaceutiske sammensætninger omfattende opioider
TWI443090B (zh) * 2007-05-25 2014-07-01 Abbvie Deutschland 作為代謝性麩胺酸受體２（ｍｇｌｕ２ 受體）之正向調節劑之雜環化合物
BRPI0815658A2 (pt) 2007-08-07 2015-02-18 Hoffmann La Roche Aril-éter pirrolidina como antagonistas do receptor nk3
KR20100103799A (ko) 2007-11-16 2010-09-28 네우렉슨 인코포레이티드 내장통을 치료하기 위한 인돌 화합물 및 방법
US8664214B2 (en) * 2010-03-30 2014-03-04 AbbVie Deutschland GmbH & Co. KG Small molecule potentiators of metabotropic glutamate receptors I
US8507535B2 (en) 2010-07-07 2013-08-13 Hoffmann-La Roche Inc. Methyl-pyrrolidine ether derivatives
JP6133790B2 (ja) * 2011-02-18 2017-05-24 ザ スクリプス リサーチ インスティテュート ミエリン形成細胞運命へのオリゴデンドロサイト前駆細胞の定方向分化
WO2012129562A2 (en) 2011-03-24 2012-09-27 The Scripps Research Institute Compounds and methods for inducing chondrogenesis
RU2014121984A (ru) 2011-10-31 2015-12-10 Ксенон Фармасьютикалз Инк. Бензолсульфонамидные соединения и их применение в качестве терапевтических средств
ES2576082T3 (es) 2012-01-31 2016-07-05 Eisai R&D Management Co., Ltd. Derivado de paroxetina
WO2013182612A1 (en) 2012-06-07 2013-12-12 Bayer Pharma Aktiengesellschaft Glucose transport inhibitors
ES2653265T3 (es) * 2012-12-28 2018-02-06 Purdue Pharma Lp Morfinanos sustituidos y el uso de éstos
US9765027B2 (en) 2014-08-22 2017-09-19 Arizona Board Of Regents On Behalf Of The University Of Arizona Substituted 1-arylethyl-4-acylaminopiperidine derivatives as opioid/alpha-adrenoreceptor modulators and method of their preparation
ES2913117T3 (es) * 2015-06-26 2022-05-31 Univ Michigan Regents Inhibidores de quinasa receptora acoplada a proteína G y métodos para el uso de los mismos

Similar Documents

Publication Publication Date Title
JP2018527354A5 (https=)
RU2475478C2 (ru) Соединения для лечения пролиферативных расстройств
JP2005526723A5 (https=)
JP2015518491A5 (https=)
JP2016506960A5 (https=)
JP2014530900A5 (https=)
JP2018048143A5 (https=)
JP2013509442A5 (https=)
IL264982B (en) Hetero(aryl)cyclopropylamine compounds as lsd1 inhibitors
JP2017508782A5 (https=)
JP2016506387A5 (https=)
JP2018515438A5 (https=)
JP2006525298A5 (https=)
JP2006524222A5 (https=)
JP2009524670A5 (https=)
RU2018114077A (ru) Биарильное производное и содержащее его лекарственное средство
JP2009535307A5 (https=)
RU2012107101A (ru) Производные пирроло[1,2-в] пиридазина как ингибиторы янус-киназы
JP2017501237A5 (https=)
JP2009523760A5 (https=)
JP2019504050A5 (https=)
JP2019510034A5 (https=)
JP2009507896A5 (https=)
RU2015117647A (ru) Новые производные пиразола
RU2015121037A (ru) Производные фенилэтилпиридина в качестве ингибиторов pde-4